Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
For the call Enhancing the European R&I system (HORIZON-WIDERA-2024-ERA-01) (deadline 12 March 2024) with the following 9 call topics a total number of 93 proposals were submitted.
The breakdown per topic is as follows:
HORIZON-WIDERA-2024-ERA-01-01 Programme level collaboration between national R&I policy-makers: 5 proposals
HORIZON-WIDERA-2024-ERA-01-03 Support for the professionalisation of research management: 7 proposals
HORIZON-WIDERA-2024-ERA-01-04 Strengthening researchers’ skills for better careers – leveraging the European Competence Framework for Researchers: 24 proposals
HORIZON-WIDERA-2024-ERA-01-07 Capacity building on Intellectual Property (IP) management to support open science: 8 proposal
HORIZON-WIDERA-2024-ERA-01-08 Global cooperation in not-for-profit open access publishing: 4 proposals
HORIZON-WIDERA-2024-ERA-01-09 Support to the development and implementation of policies and practices for reproducibility of scientific results: 4 proposals
HORIZON-WIDERA-2024-ERA-01-10 Policy coordination to support all aspects of inclusive Gender Equality Plans and policies in the ERA: 1 proposals
HORIZON-WIDERA-2024-ERA-01-11 Support to the implementation of inclusive gender equality plans: 22 proposals
HORIZON-WIDERA-2024-ERA-01-12 Next generation AI and Human Behaviour: promoting an ethical approach: 18 proposals
Evaluation results are expected to be communicated in July 2024.
Source: European Commission Funding and tender portal
2024-11-05
|
2 months ago |
GENDERACTIONplus open letter to support gender equality in research and innovation |
2024-10-28
|
2 months ago |
New European Research Area Communication adopted by the European Commission |
2024-09-30
|
3 months ago |
GenderSAFE call to sign the pledge for zero tolerance to gender-based violence |
2024-09-20
|
4 months ago |
EU Award for Gender Equality Champions third edition open for submissions |
2024-09-02
|
4 months ago |
Horizon Europe Impact training session and Proposal workshop coming up this Autumn |
2024-07-12
|
6 months ago |
Science comes to town - call for applications |
2024-06-12
|
7 months ago |
ERA Talent Platform launched |
2024-04-23
|
8 months ago |
Main changes in the amended version of the Horizon Europe WIDERA work programme for t... |
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.